Institutional investors purchased a net $1.2 million shares of THRX during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 84.33% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREDIT SUISSE AG Bought 1.2 Thousand shares of Theravance Inc
STATE STREET GLOBAL ADVISORS LTD... Sold 26.00 shares of Theravance Inc